ICTS Investigator Aims to Implement Widespread Use of Visual Key Information for Informed Consent in Research Studies
Ever since Mary Politi, PhD, arrived at WashU back in 2009, she has believed the informed consent process for research study participants could be improved. Many people who think about joining research studies comment on the length and complexity of informed consent documents. They often assume these documents are used for legal purposes rather than […]
Former KL2 Scholar Awarded NIA Funding for Alzheimer’s Caregiver Research
Jacquelyn Benson, PhD, Associate Professor of Medicine in the WashU Division of Palliative Medicine, has recently been awarded funding from the National Institute on Aging to conduct a randomized controlled trial to test a 1:1, paraprofessional peer-delivered multicomponent support intervention for family caregivers of persons living with Alzheimer’s disease (AD). This intervention is designed to […]
WashU Investigator credits ICTS resources and funding on her path to $2.8 million grant from the National Institutes of Health (NIH)
Christine O’Brien, PhD, an assistant professor of biomedical engineering at Washington University in St. Louis, was recently granted $2.8 million from the NIH to develop a wearable device to track blood loss to prevent postpartum hemorrhage – the leading cause of maternal death worldwide. The goal is to design a wearable device that tracks blood […]
ICTS Extends its Gratitude and Bids Farewell to Longtime Associate Director
Effective September 1, 2025, Christina Gurnett, MD, PhD, will begin her tenure as Head of the Division of Pediatric Neurology at the Children’s Hospital of Philadelphia and the University of Pennsylvania. Dr. Gurnett, the A. Ernest & Jane G. Stein Professor of Neurology, began her journey at Washington University and St. Louis Children’s Hospital in […]
ICTS-supported facility accelerates translation of promising research into improving outcomes for cancer and other related diseases
Housed within the Siteman Cancer Center, the Biologic Therapy Core Facility (BTCF) partners with physicians and scientists to manufacture, characterize, and release complex, clinical-grade cell and gene therapy products, imaging agents, and other biologics to support early-phase clinical trials. The BTCF also supports cellular (e.g. hematopoietic stem cell selections) and tissue therapies (e.g. parathyroid cryopreservation) […]